I'm interested to know what operating systems people here use. This will help me and others decided what platforms to focus testing on.
Unconfigured Ad
Collapse
X
-
What Operating System Do You Use For Analysis?
82Linux 32-bit6.10%5Linux 64-bit59.76%49Unix variant0.00%0Windows XP3.66%3Windows 7 (32-bit)1.22%1Windows 7 (64-bit)2.44%2Mac OS X (Intel)19.51%16Mac OS X (PowerPC)3.66%3Cloud based1.22%1Other (Please mention)2.44%2Tags: None
-
-
I'd also be interested to know what distro the Linux users use. This may help as well. Perhaps maintainers or others could also add why they use this particular distro?
I run my analysis on an Ubuntu server, Jaunty. I just use the available server, so I can't say anything useful about why it runs Jaunty.
-
-
The workstation I use currently runs Slackware64.-13.0, but it will be upgraded to 13.1 sometime soon. I chose Slackware due to my own familiarity with it, plus support is readily available. I've had people in the Slackware community help me get things working, even if they didn't know much of the tools themselves.
Comment
-
-
Wow, I'm surprised there are so many Macs... good thing the new SpliceMap supports OS X. I'll make a post about that later.
Comment
-
-
I think most of the people that uses mac, they use them for the initial coding and prototyping, idea testing and then they through the real deal to a HPC cluster, typically linux based.Originally posted by john_mu View PostWow, I'm surprised there are so many Macs... good thing the new SpliceMap supports OS X. I'll make a post about that later.-drd
Comment
-
-
Or work on smaller organisms like viruses or bacteria where you don't need so much RAM.Originally posted by drio View PostI think most of the people that uses mac, they use them for the initial coding and prototyping, idea testing and then they through the real deal to a HPC cluster, typically linux based.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
16 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
32 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
||
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
43 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
29 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|

Comment